Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease

Journal of Neurochemistry

Volumn 71, Issue 2, 1998, Pages 767-774

  Boissière, Florence ^a   Faucheux, Baptiste ^a   Duyckaerts, Charles ^a   Hauw, Jean Jacques ^a   Agid, Yves ^a   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alzheimer's disease; Glutamic acid decarboxylase; In situ hybridization; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; GLUTAMATE DECARBOXYLASE; MESSENGER RNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NEUROPATHOLOGY; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN;

EID: 0031784321     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71020767.x     Document Type: Article

References (41)

1. Beckstead R. M., Domesick V. B., and Nauta W. J. H. (1979) Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191-217.
2. Bu D. F., Erlander M. G., Hitz B. C., Tillakaratne N. J. K., Kaufman D. L., Wagner-McPherson C. B., Evans G. A., and Tobin A. J. (1992) Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. USA 89, 2115-2119.
3. Chesselet M.-F., Weiss L., Wuenschell C., Tobin A. J., and Affolter H.-U. (1987) Comparative distribution of RNAs for glutamic acid decarboxylase, tyrosine hydroxylase and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J. Comp. Neurol. 262, 125-140.
4. Davies P. (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 171, 319-327.
5. Dimova R., Vuillet J., Niéoullon A., and Kerkérian-Le Goff F. (1993) Ultrastructural features of the choline acetyltransferase-containing neurons and relationships with nigral dopaminergic and cortical afferent pathways in the rat striatum. Neuroscience 53, 1059-1071.
6. Faden A. I. and Townsend J. J. (1976) Myoclonus in Alzheimer's disease: a confusing sign. Arch. Neurol. 33, 278-280.
7. Fontaine B., Sassoon D., Buckingham M., and Changeux J.-P. (1988) Detection of the nicotinic acetylcholine receptor subunit mRNA by in situ hybridization at neuromuscular junction of 15-day-old chick striatal muscles. EMBO J. 7, 603-609.
8. Frassen E. H., Reisberg B., Kluger A., Sinaiko E., and Boja C. (1991) Cognition-independent neurologic symptoms in normal aging and probable Alzheimer's disease. Arch. Neurol. 48, 148-154.
9. Gottfries C. G. (1990) Neurochemical aspects of dementia disorders. Dementia 1, 56-64.
10. Graybiel A. M. and Ragsdale C. W. J. (1978) Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc. Natl. Acad. Sci. USA 75, 5723-5726.
11. Hyman B. T., Duyckaerts C., and Christen Y. (1997) Connections, Cognition and Alzheimer's Disease: Research and Perspectives in Alzheimer's Disease. Springer-Verlag, Berlin.
12. Kastner A., Hirsch E. C., Agid Y., and Javoy-Agid F. (1993) Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Brain Res. 606, 341-345.
13. Kordower J. H., Gash D. M., Bothwell M., Hersh L. B., and Mufson E. J. (1989) Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol. Aging 10, 67-74.
14. Lehéricy S., Hirsch E. C., Cervera P., Hersh L. B., Hauw J.-J., Ruberg M., and Agid Y. (1989) Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 8580-8584.
15. Lehéricy S., Hirsch E. C., Cervera-Piérot P., Hersh L. B., Bakchine S., Piette F., Duyckaerts C., Hauw J.-J., Javoy-Agid F., and Agid Y. (1993) Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Comp. Neurol. 330, 15-31.
16. Lehéricy S., Brandel J.-P., Hirsch E. C., Anglade P., Villares J., Scherman D., Duyckaerts C., Javoy-Agid F., and Agid Y. (1994) Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography. Brain Res. 659, 1-9.
17. 67 mRNA. Eur. J. Neurosci. 7, 1199-1209.
18. 67 messenger RNA. Neurology 45, 127-134.
19. Levy R., Hazrati L.-N., Herrero M.-T., Vila M., Hassani O.-K., Mouroux M., Ruberg M., Asensi H., Agid Y., Féger J., Obeso J. A., Parent A., and Hirsch E. C. (1997) Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience 76, 335-343.
20. Liu Y., Stern Y., Chun M. R., Jacobs D. M., Yau P., and Goldman J. E. (1997) Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann. Neurol. 41, 368-374.
21. Lynd-Balta E. and Haber S. N. (1994) The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum. Neuroscience 59, 625-640.
22. Mann D. M. A., Yates P. O., and Marcyniuk B. (1987) Dopaminergic neurotransmitter system in Alzheimer's disease and in Down's syndrome at middle age. J. Neurol. Neurosurg. Psychiatry 50, 341-344.
23. Mesulam M. M. and Geula C. (1988) Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and cholineacetyltransferase. J. Comp. Neurol. 275, 216-240.
24. Montfort J.-C., Javoy-Agid F., Hauw J.-J., Dubois B., and Agid Y. (1985) Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain 108, 301-313.
25. Mufson E. J., Mash D. C., and Hersh L. B. (1988) Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease. Ann, Neurol. 24, 623-629.
26. Mufson E. J., Bothwell M., and Kordower J. H. (1989) Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp. Neurol. 105, 221-232.
27. Nagai T., McGeer P. L., Peng J. H., McGeer E. G., and Dolman C. E. (1983) Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls. Neurosci. Lett. 36, 195-199.
28. Parent A. and Hazrati L.-N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20, 91-127.
29. Pearson R. C. A., Esiri M. M., Hiorns R. W., Wilcock G. K., and Powell T. P. S. (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 82, 4531-4534.
30. Reinikainen K. J., Paljärvi L., Huuskonen M., Soininen H., Laakso M., and Riekkinen P. J. (1988) A post-mortem study of noradrenergic, serotoninergic and GABAergic neurons in Alzheimer's disease. J. Neurol. Sci. 84, 101-116.
31. Reinikainen K. J., Soininen H., and Riekkinen P. J. (1990) Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J. Neurosci. Res. 27, 576-586.
32. Selden N., Geula C., Hersh L. B., and Mesulam M. M. (1994a) Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience 60, 621-636.
33. Seiden N., Mesulam M. M., and Geula C. (1994b) Human striatum: the distribution of neurofibrillary tangles in Alzheimer's disease. Brain Res. 648, 327-331.
34. Soghomonian J. J., Gonzales C., and Chesselet M.-F. (1992) Messenger RNAs encoding gluatamate decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Res. 576, 68-79.
35. Soininen H., Laulumaa V., Helkala E., Hartikainen P., and Riekkinen P. J. (1992) Extrapyramidal signs in Alzheimer's disease. J. Neural Transm. 4, 107-119.
36. Stern Y., Albert M., and Brandt J. (1994) Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the predictors study. Neurology 44, 2300-2307.
37. Strada O., Vyas S., Hirsch E. C, Ruberg M., Brice A., Agid Y., and Javoy-Agid F. (1992) Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study. Proc. Natl. Acad. Sci. USA 89, 9549-9553.
38. Tyrrell P. J., Sawle G. V., Ibanez V., Bloomfield P. M., Leenders K. L., Frackowiak R. S., and Rossor M. N. (1990) Clinical and positron emission tomographic studies in the "extrapyramidal syndrome" of dementia of the Alzheimer type. Arch. Neurol. 47, 1318-1323.
39. Vila M., Herrero M.-T., Levy R., Faucheux B., Ruberg M., Guillen J., Luquin M. R., Guridi J., Javoy-Agid F., Agid Y., Obeso J. A., and Hirsch E. C. (1996) Consequence of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 46, 802-809.
40. Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T., and DeLong M. R. (1981) Alzheimer disease: evidence for a selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122-126.
41. Yates C. M., Butterworth J., Tennant M. C., and Gordon A. (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J. Neurochem. 55, 1624-1630.